About Michael Kope
Form D filings for Cyclarity Therapeutics from 2019 to 2024 list Michael Kope as executive officer and director.
Michael Kope first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Kope in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Kope works with at each company, as listed on that company's latest Form D.
Cyclarity Therapeutics, Inc. · Form D, Dec 30, 2024
MC
Matthew O'Connor
Co-Chief Executive Officer and director